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CASE REPORT Open Access
Case report of homozygous E200D
mutation of PRNP in apparently sporadic
Creutzfeldt-Jakob disease
Ahamad Hassan1, Tracy Campbell2, Lee Darwent2, Hans Odd3, Alison Green4, John Collinge2,3 and
Simon Mead2,3*
Abstract
Background: Inherited prion diseases are rare autosomal dominant disorders associated with diverse clinical
presentations. All are associated with mutation of the gene that encodes prion protein (PRNP). Homozygous
mutations with atypical clinical phenotypes have been described but are extremely rare.
Case presentation: A Chinese patient presented with a rapidly progressive cognitive and motor disorder in the
clinical spectrum of sCJD. Investigations strongly suggested a diagnosis of CJD. He was found to carry a
homozygous mutation at PRNP codon 200 (E200D), but there was no known family history of the disorder. The
estimated allele frequency of E200D in East Asian populations is incompatible with it being a highly penetrant
mutation in the heterozygous state.
Conclusion: In our view the homozygous PRNP E200D genotype is likely to be causal of CJD in this patient.
Homotypic PrP interactions are well known to favour the development of prion disease. The case is compatible
with recessively inherited prion disease.
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Background
Prion diseases are rare and transmissible neurodegenera-
tive disorders associated with accumulation of assem-
blies of misfolded prion protein (PrP). Over 85% of the
annual incidence of human prion disease takes the form
of sCJD, typically presenting as a rapidly progressive de-
mentia with ataxia, myoclonus and motor problems.
Inherited prion diseases (IPD) comprise the large major-
ity of the remainder of cases, which have a wide variety
of clinical presentations, sometimes indistinguishable
from sCJD, but often with much slower clinical change
[1]. All IPD is associated with coding mutation of the
gene that encodes prion protein (PRNP) and a large
number of variants have been described. IPD segregates
in families as an autosomal dominant trait, although
some variants have relatively late clinical onset and car-
riers may die from other conditions before the disease
manifests. The most common mutation that causes IPD,
E200K, has a clinical presentation that is hard to distin-
guish from sCJD. E200K is frequent in particular regions
of the world, and a small number of patients with a
homozygous E200K mutation have been seen, having a
slightly earlier onset of disease compared with heterozy-
gous patients, and some altered clinical features [2]. A
patient with a homozygous Q212P mutation has been
reported. Here we present and discuss the case of a
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patient with CJD and a homozygous E200D mutation,
not previously described.
Case presentation
A 61 year old man of Chinese ethnicity with no signifi-
cant past medical history presented with a 6 week history
of behavioural change including aggression, poor mem-
ory, praxis problems, slurred speech and loss of balance.
There was a recent history of weight loss and vomiting.
On examination he appeared to understand and speak
English but the content of his speech was disorganised
and he appeared confused. Examination revealed normal
eye movements. He was dysarthric and demonstrated
ataxia in all four limbs with truncal ataxia also. There
was no myoclonus, or pyramidal or extrapyramidal signs
at this stage.
The patient’s father died aged 61 of a non-neurological
condition, the status of the patient’s mother is not
known. There were no prior diagnoses of CJD or de-
mentia in the wider family known to the patient’s
children.
Initial work-up showed normal full blood count,
standard biochemical profile, B12 and folate. Paraneo-
plastic, VGKC and anti-NMDA antibodies were negative
as were HIV, syphilis and hepatitis serology. EEG was re-
ported as mild slowing only, with no periodic sharp wave
complexes. A brain MRI showed abnormal symmetric
restricted diffusion in the corpus striatum bilaterally and
cortical diffusion restriction in the frontal lobes and
around the parieto-occipital fissure bilaterally (Fig. 1).
CSF was acellular, with normal protein and glucose. CSF
Viral PCR was negative but 14–3-3 and S-100b were ab-
normal. A diagnosis of CJD was confirmed by a positive
reaction when CSF was analysed in quadruplicate by
RT-QuIC (real-time quaking induced conversion, Fig. 2).
The E200D mutation was detected by bidirectional se-
quencing and was linked to a methionine homozygous
genotype at polymorphic codon 129.
Over the course of his admission his neurological state
rapidly worsened. He began to exhibit startle responses
Fig. 1 Axial diffusion weighted image showing bilateral high signal
in the striatum and cortex
Fig. 2 CSF RT-QuIC trace of reaction seeded with 30 μl of CSF (blue) and 15 μl (orange). Results expressed as the mean of the two highest of
four replicates
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and multifocal myoclonus. Later he became increasingly
agitated with distressing visual hallucinations which were
managed with lorazepam. In the final days of his illness
he became mute and bed bound with generalised spasti-
city. Following discussion with his family palliative care
was commenced. Death was certified within 4 weeks of
admission (total duration 10 weeks).
Discussion and conclusions
Although no post-mortem examination was done the
diagnosis of this patient is almost certain. The MRI find-
ings and RT-QuIC test are both highly specific in isola-
tion. We are not aware of a single report in the
literature of a false positive diagnosis when both of these
tests are abnormal. The E200D variant has been found
in the East Asian population with an allele frequency of
approximately 1 in 10,000 (based on 2 occurrences in
18,394 East Asian exomes reported on gnomAD) [3]. As
the variant has not been reported in the heterozygous
state in any CJD patient, it is highly likely to be benign
as this genotype.
The homozygous E200D genotype has never been ob-
served in population databases. It should be extremely
rare and found predominantly in families with some
degree of consanguinity, which was possible but not
certain in this case. Family history is a good guide to
help decision making about the penetrance of novel
PRNP variants, however in this case we would not
expect a family history as the parents are expected to be
heterozygous carriers of a benign variant. In our opinion,
it seems likely that the homozygous E200D genotype
was causal in this patient, the alternative possibility is of
a coincidental occurrence of sCJD with a genotype of
PRNP never before observed [4]. The situation seems
similar to the Q212P variant of PRNP which appears to
have low penetrance in the heterozygous state, but has
caused an atypical early onset prion disease in the
homozygous state [5].
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